INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Dec 17, 2013 |
SVP Administration & Asst Secr
Trans History: 645
|
SVP Administration & Asst Secr | Form 4 | Other acquisition or disposition | -- | -- | 750 |
| Dec 17, 2013 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Other acquisition or disposition | -- | -- | 1,589 |
| Dec 17, 2013 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 20,000 |
| Dec 17, 2013 |
SVP Research and Development S
Trans History: 660
|
SVP Research and Development S | Form 4 | Other acquisition or disposition | -- | -- | 5,536 |
| Dec 17, 2013 |
Director, Pres Regeneron Labs
Trans History: 628
|
Director, Pres Regeneron Labs | Form 4 | Other acquisition or disposition | -- | -- | 5,591 |
| Dec 13, 2013 |
Director, Pres Regeneron Labs
Trans History: 628
|
Director, Pres Regeneron Labs | Form 4 | Other acquisition or disposition | -- | -- | 5,591 |
| Dec 04, 2013 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 65,759 |
| Dec 04, 2013 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 15,162 |
| Dec 04, 2013 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 3 |
| Dec 04, 2013 |
Director, Chairman of the Board
Trans History: 742
|
Director, Chairman of the Board | Form 4 | Other acquisition or disposition | -- | -- | 114,750 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.